W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Communication – report on tariff setting for outpatient specialist care services: bone marrow aspiration biopsy, bone marrow trepanobiopsy, external consultations

more...

Communication on the meeting of the Tariff Council on 01.09.2022

more...

Communication on the meeting of the Tariff Council on 25.08.2022

more...

The Meeting of the Tariffs Council No. 21/2022 of 25.08.2022 – update

more...

Position of the Transparency Council – Renastep

more...

Opinion of the Transparency Council – entecavirum and tenofovirum disoproxilum

more...

Opinion of the Transparency Council – health policy programme in the field of perinatal care (Municipality of Stare Babice)

more...

Recommendation of the President – on qualifying selected diagnostic, ultrasound, invasive, electrophysiological, and functional examinations as well as specialist advice and consultations for the list of guaranteed health care services in the scope of primary health care

more...

Recommendation of the President – Milupa Basic-P

more...

The Meeting of the Transparency Council No. 35/2022 of 05.09.2022

more...

The Meeting of the Tariffs Council No. 20/2022 of 25.08.2022 – update

more...

Position of the Transparency Council – Milupa Basic-P

more...

Position of the Transparency Council – Ospolot (sultiam)

more...

Position of the Transparency Council – Jardiance (empagliflozyna)

more...

Position of the Transparency Council – Yervoy (ipilimumab)

more...

Position of the Transparency Council – Opdivo (niwolumab)

more...

Position of the Transparency Council – Tremfya (guselkumabum)

more...

Opinion of the Transparency Council – methotrexatum

more...

Opinion of the Transparency Council – cyclophosphamidum

more...

Opinion of the Transparency Council – azathioprinum

more...

Position of the Transparency Council – Empliciti (elotuzumab)

more...

Position of the Transparency Council – Ontozry (cenobamat)

more...

Opinion of the Transparency Council – recommended medical technologies, actions to be carried out under health policy programmes and the implementation conditions for the glaucoma prevention programmes

more...

Position of the Transparency Council – qualifying of health care services financed from the entrusted budget and provided on the order of a primary care physician

more...